Get started
Author

Rakesh Raman

Observed name: R. Raman
ORCID: 0000-0003-0159-7227
Observed ORCID: 0000-0003-0159-7227
OpenAlex ID: A5075069119
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
2020 · Christopher C Parker, Noel W Clarke, et al. · The Lancet · 432
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial
2024 · Chris C Parker, Howard Kynaston, et al. · The Lancet · 88
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)
2024 · C.C. Parker, P.M. Petersen, et al. · Annals of Oncology · 70
PDF
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
2024 · Chris C Parker, Noel W Clarke, et al. · The Lancet · 58
Timing of radiotherapy (RT) after radical prostatectomy (RP): First results from the RADICALS RT randomised controlled trial (RCT) [NCT00541047]
2019 · C. Parker, N.W. Clarke, et al. · Annals of Oncology · 47
PDF
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)
2024 · Chris C. Parker, Noel W. Clarke, et al. · European Urology · 35
Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes
2021 · Sook-Yee Yoon, Siu Wan Wong, et al. · Journal of Medical Genetics · 24
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 7
Effect of the learning curve on survival after laparoscopic liver resection for colorectal metastases
2022 · Hiba Shanti, Rakesh Raman, et al. · BJS Open · 5
PDF
The prevalence and fate of the defunctioning stoma in patients with anal cancer: a regional experience following the ACT II trial
2017 · L. R. Poynter, R. Raman, et al. · Colorectal Disease · 4
Metastatic Anorectal Melanoma Presenting as Seizures: An Infrequent Culprit
2022 · Joao Galante, Sola Adeleke, et al. · Diseases · 2
PDF
Outcome of radical chemoradiation in node-positive bladder cancer: The Kent experience
2025 · S. Bhusal, R. Raman, et al. · Clinical Oncology
Relevance of adjuvant chemotherapy in elderly patients with low rectal tumors.
2023 · Sola Adeleke, Aaron Davies, et al. · Journal of Clinical Oncology
PDF
Use of Novel Imaging for Patient Selection for Stereotactic Ablative Radiotherapy (SABR) in Oligometastatic Prostate Cancer (PCa): Does the PET Tracer Make a Difference?
2022 · J.R. Galante, S. Adeleke, et al. · Clinical Oncology
O-L01 Learning curve for laparoscopic liver resection: does it affect survival in colorectal liver metastasis?
2021 · Hiba Shanti, Rakesh Raman, et al. · British journal of surgery
PDF
414P Does adjuvant chemotherapy compared to surveillance improve recurrence free and overall survival in stage 3 rectal cancer patients?
2021 · S.M. Adeleke, S. George, et al. · Annals of Oncology
PDF
Intensity-Modulated Chemoradiation for Anal Cancer: A South-East UK experience
2020 · I. Vasiliadou, S.K. Nagpal, et al. · International Journal of Radiation Oncology*Biology*Physics
Medical Management of Renal Cell Cancer
2020 · Jennifer Turner, Adrian Simoes, et al. · IntechOpen eBooks
PDF
Predictors of response to 3rd line TAS-102 chemotherapy in metastatic colorectal cancer
2019 · V. Angelis, T. Young, et al. · Annals of Oncology
Kent experience of radical chemoradiotherapy for muscle invasive bladder cancer.
2017 · Jessica Gough, Mathini Sridharan, et al. · Journal of Clinical Oncology
Works count: 21
Citation count: 830
H-index: 8
I10-index: 8
Year
Topic
Type